Dr. Merit Cudkowicz, MD

• Neurology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Harvard Medical School

  Medical School, 1990

• English

• Italian

• Discovery and Verification of Amyotrophic Lateral Sclerosis Biomarkers by Proteomics, 2010-09-30

• Serum Urate at Trial Entry and ALS Progression in EMPOWER, 2016-09-28

• Profound Muscle Weakness and Pain after One Dose of Actonel, 2009-10-11

• A High-Density Genome-Wide Association Screen of Sporadic ALS in US Veterans, 2012-03-28

• Regional prefrontal cortical atrophy predicts specific cognitive-behavioral symptoms in ALS-FTD, 2021-02-15

• Intrinsic Membrane Hyperexcitability of ALS Patient-Derived Motor Neurons, 2014-04-03

• Serum Nogo-A levels are not elevated in amyotrophic lateral sclerosis patients, 2009-09-22

• Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics - An AI-Enabled Biological Target Discovery Platform, 2022-06-28

• Systemic Pharmacokinetics and Cerebrospinal Fluid Uptake of Intravenous Ceftriaxone in Patients with Amyotrophic Lateral Sclerosis, 2014-05-16

• Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients, 2021-06-24

• New considerations in the design of clinical trials for amyotrophic lateral sclerosis, 2012-02-14

• Natural History of Infantile-Onset Spinal Muscular Atrophy, 2017-12-08

• Military service and amyotrophic lateral sclerosis in a population-based cohort, 2015-09-18

• A Phase I, Randomised, First-in-Human Study of an Antisense Oligonucleotide Directed Against SOD1 Delivered Intrathecally in SOD1-Familial ALS Patients, 2013-03-29

• Analysis of participant withdrawal in Huntington disease clinical trials, 2017-07-23

• Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone, 2015-11-14

• Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice, 2014-11-27

• Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis, 2012-08-17

• Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial, 2020-12-31

• Job-related formaldehyde exposure and ALS mortality in the United States, 2015-07-13

• Defining SOD1 ALS natural history to guide therapeutic clinical trial design, 2016-06-03

• Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis, 2013-04-17

• Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial, 2021-12-24

• Oral Repeated Dose Toxicity Studies of Coenzyme Q10 in Beagle Dogs, 2012-01-20

• Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS, 2014-08-14

• Uric acid levels predict survival in men with amyotrophic lateral sclerosis, 2012-02-10

• Answer ALS, A Large-Scale Resource for Sporadic and Familial ALS Combining Clinical and Multi-Omics Data from Induced Pluripotent Cell Lines, 2022-02-03